RETRACTED: Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy
Open Access
- 16 November 2008
- journal article
- retracted article
- Published by Oxford University Press (OUP) in Brain
- Vol. 131 (12) , 3311-3334
Abstract
Insulin deficiency in type I diabetes may lead to cognitive impairment, cerebral atrophy and white matter abnormalities. We studied the impact of a novel delivery system using intranasal insulin (I-I) in a mouse model of type I diabetes (streptozotocin-induced) for direct targeting of pathological and cognitive deficits while avoiding potential adverse systemic effects. Daily I-I, subcutaneous insulin (S-I) or placebo in separate cohorts of diabetic and non-diabetic CD1 mice were delivered over 8 months of life. Radio-labelled insulin delivery revealed that I-I delivered more rapid and substantial insulin levels within the cerebrum with less systemic insulin detection when compared with S-I. I-I delivery slowed development of cognitive decline within weekly cognitive/behavioural testing, ameliorated monthly magnetic resonance imaging abnormalities, prevented quantitative morphological abnormalities in cerebrum, improved mouse mortality and reversed diabetes-mediated declines in mRNA and protein for phosphoinositide 3-kinase (PI3K)/Akt and for protein levels of the transcription factors cyclic AMP response element binding protein (CREB) and glycogen synthase kinase 3β (GSK-3β) within different cerebral regions. Although the murine diabetic brain was not subject to cellular loss, a diabetes-mediated loss of protein and mRNA for the synaptic elements synaptophysin and choline acetyltransferase was prevented with I-I delivery. As a mechanism of delivery, I-I accesses the brain readily and slows the development of diabetes-induced brain changes as compared to S-I delivery. This therapy and delivery mode, available in humans, may be of clinical utility for the prevention of pathological changes in the diabetic human brain.Keywords
This publication has 123 references indexed in Scilit:
- Diabetes-Related Complications, Glycemic Control, and Falls in Older AdultsDiabetes Care, 2008
- Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neuronsNature Neuroscience, 2008
- Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS studyJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Long-Term Effect of Diabetes and Its Treatment on Cognitive FunctionNew England Journal of Medicine, 2007
- Global and Regional Effects of Type 2 Diabetes on Brain Tissue Volumes and Cerebral VasoreactivityDiabetes Care, 2007
- Brain Lesions on MRI in Elderly Patients with Type 2 Diabetes MellitusEuropean Neurology, 2006
- Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's diseaseNature Clinical Practice Neurology, 2006
- Alzheimer‐like changes in protein kinase B and glycogen synthase kinase‐3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathwayJournal of Neurochemistry, 2006
- Mechanism of mitochondrial dysfunction in diabetic sensory neuropathyJournal of the Peripheral Nervous System, 2003
- Effects of insulin-dependent diabetes on learning and memory efficiency in adultsJournal of Clinical and Experimental Neuropsychology, 1993